June 17, 2024

IPOPI speaks at the Plasma4Life roundtable discussion

Ms Roberta Anido de Pena, IPOPI Board Member and President of the Argentinian PID patient organisation, and Ms Leire Solis, IPOPI’s Health Policy and Advocacy Senior Manager, were speakers at a breakfast roundtable hosted by the United Nations Institute for Training and Research (UNITAR) on “Plasma4Life: Bridging the gap in access to plasma and plasma-derived medicinal products” on May 29, 2024, in Geneva, Switzerland.

The roundtable discussion, chaired by Mr Jan Plavcan, from UNITAR, aimed at presenting the progress made by the project in which patients, medical experts, governments, the private sector and other stakeholders have teamed up to explore potential solutions to increase access to plasma for the development of immunoglobulin replacement therapies and other plasma-derived medicines. The meeting was opened by Mr Alex Mejia, Director, Division for People and Social Inclusion, UNITAR, and by Mr Giles Platford, President of the plasma-derived therapies business unit, Takeda.

Other speakers in this roundtable discussion included:

  • Prof Adli Ali, Head of immunology and rheumatology services, hospital Pakar Kanak-Kanak UKM (Malaysia) and IPOPI’s Medical Advisor.
  • Ms Nancy Di Salvo, International affairs’ director, GBS-CIDP Foundation International;
  • Mr Alain Baumann, CEO, World Federation of Hemophilia,
  • Prof Guido Cavaletti, head of the neuroimmunology centre, University of Milano-Bicocca (Italy).

Plasma4Life is a neutral platform facilitated by UNITAR that aims at increasing awareness, building partnerships and facilitating access to the latest scientific knowledge and best practices about plasma and plasma-derived medicinal products. The project also seeks to support countries in their identification of the best national solution to improve the plasma ecosystems and increase patient access to care.

More information about Plasma4Life can be found here: Blood Plasma Platform (plasma4.life)